Literature DB >> 24629993

Team science and the creation of a novel rotavirus vaccine in India: a new framework for vaccine development.

Maharaj K Bhan1, Roger I Glass2, Krishna M Ella3, Nita Bhandari4, John Boslego5, Harry B Greenberg6, Krishna Mohan3, George Curlin7, T S Rao8.   

Abstract

Mesh：

Substances：

Year:  2014        PMID： 24629993     DOI： 10.1016/S0140-6736(14)60191-4

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  10 in total

Review 1.  Vaccine development and trials in low and lower-middle income countries: Key issues, advances and future opportunities.

Authors:  Amy Grenham; Tonya Villafana
Journal:  Hum Vaccin Immunother       Date:  2017-09-02       Impact factor: 3.452

Review 2.  Systematic review of the economic value of diarrheal vaccines.

Authors:  Richard Rheingans; Mirna Amaya; John D Anderson; Poulomy Chakraborty; Jacob Atem
Journal:  Hum Vaccin Immunother       Date:  2014-05-27       Impact factor: 3.452

Review 3.  A brief history of vaccines & vaccination in India.

Authors:  Chandrakant Lahariya
Journal:  Indian J Med Res       Date:  2014-04       Impact factor: 2.375

4.  "Health system approach" for improving immunization program performance.

Authors:  Chandrakant Lahariya
Journal:  J Family Med Prim Care       Date:  2015 Oct-Dec

Review 5.  Experiences with rotavirus vaccines: can we improve rotavirus vaccine impact in developing countries?

Authors:  A D Steele; J C Victor; M E Carey; J E Tate; D E Atherly; C Pecenka; Z Diaz; U D Parashar; C D Kirkwood
Journal:  Hum Vaccin Immunother       Date:  2019-02-08       Impact factor: 3.452

Review 6.  The rotavirus vaccine development pipeline.

Authors:  Carl D Kirkwood; Lyou-Fu Ma; Megan E Carey; A Duncan Steele
Journal:  Vaccine       Date:  2017-04-07       Impact factor: 3.641

7.  ROTAVAC® does not interfere with the immune response to childhood vaccines in Indian infants: A randomized placebo controlled trial.

Authors:  Temsunaro Rongsen Chandola; Sunita Taneja; Nidhi Goyal; Kalpana Antony; Kiran Bhatia; Deepak More; Nita Bhandari; Iksung Cho; Krishna Mohan; Sai Prasad; Gvja Harshavardhan; Tataji Surender Rao; Sudhanshu Vrati; Maharaj Kishan Bhan
Journal:  Heliyon       Date:  2017-05-16

8.  Vaccine Impact Data Should Support Country Decision Making.

Authors:  E Anthony S Nelson; A Duncan Steele
Journal:  J Infect Dis       Date:  2017-06-01       Impact factor: 5.226

9.  Quality vaccines for all people: Report on the 16th annual general meeting of the Developing Countries Vaccine Manufacturers' Network, 05-07th October 2015, Bangkok, Thailand.

Authors:  Sonia Pagliusi; Ching-Chia Ting; Sumana Khomvilai
Journal:  Vaccine       Date:  2016-03-03       Impact factor: 3.641

10.  Genetic Diversity of Human Rotavirus A Among Hospitalized Children Under-5 Years in Lebanon.

Authors:  Houda H Harastani; Lina Reslan; Ahmad Sabra; Zainab Ali; Moza Hammadi; Soha Ghanem; Farah Hajar; Ghassan M Matar; Ghassan S Dbaibo; Hassan Zaraket
Journal:  Front Immunol       Date:  2020-02-26       Impact factor: 7.561
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.